Specifically, lysyl oxidase (LOX) contributed to the remodeling of the ECM, which ultimately promoted bone metastases of breast cancer, while miR- 30b exerted an anti-bone metastatic effect by targeting LOX 69. The gene discussed is LOX; the disease is breast cancer.